bio stocks

South Korean private equity (PE) firms are having trouble fundraising as institutional investors' capital for new investment is drying up amid inter...

South Korean biopharmaceutical giant Celltrion Inc. announced 654.6 billion won ($478.2 million) in revenue and 213.8 billion won in operating profi...

CJ Corp. announced it will strengthen its research and development (R&D) efforts in the bio and healthcare sectors. CJ CheilJedang Corp. ...

Several corporations have recently sold stocks and real estate apparently to boost liquidity and repay maturing debts amid the "three high" era of h...

South Korea last week completed the process needed to launch a stock market stabilization fund of 10.76 trillion won ($7.6 billion). The timing for ...

BJ Biochem Inc. is a startup that develops various differentiated materials in the preservatives, disinfectants and surface active agent (surfactant...

Monthly average deposits for stock investment in South Korea are poised to drop below 50 trillion won ($35.1 billion) for the first time since July ...

Peak Bio Co., a South Korean biopharmaceutical company, is debuting on the Nasdaq through a merger with US blank cheque company Ignyte Acquisition C...

US private equity giant The Carlyle Group and South Korean energy-to-retail conglomerate GS Group will acquire Medit Corp., the world’s third-...

South Korean biopharmaceutical firms are facing challenges in clinical trials overseas alongside the rising Korean won to the US dollar exchange rat...

South Korea’s online portal giant Naver Corp. is poised to hire an investor relations (IR) executive whose chief responsibility will be to com...

South Korea’s cloud service provider NHN Cloud Corp. is eyeing 1.1 trillion won ($776 million) corporate value via a new stock issuance, marki...

Samsung Electronics Co. set up a task force team dedicated to increasing its shareholder value last month, according to industry sources on Oct. 4. ...

South Korea is set to complete the process for a stock market stabilization fund of 10 trillion won ($7 billion) by the middle of this month, to be ...

South Korea’s three largest companies by market cap -- Samsung Electronics Co, LG Energy Solution Co. and SK Hynix Inc. -- were heavily short ...

South Korea is set to take measures to stabilize local stock and bond markets hit by global interest rate hikes amid growing risks of a worldwide ec...

South Korea's stock market tumbled to its lowest level in more than two years on Wednesday, as fears of a slowing global economy and rising inflatio...

South Korea’s main bourse Kospi dropped 1.81% to finish at 2,290.00 on Sept. 23, hitting a new low closing for the year amid growing woes over...

South Korea’s top mobile carrier SK Telecom Co. is expanding its business portfolio with quantum technology, even into industries that are unr...

Shares in EcoPro BM Co., a cathode material maker used in electric vehicle batteries, topped the list of South Korean stocks, for which an increased...

President Joe Biden’s plan to support the US biomanufacturing infrastructure aimed at containing China’s clout is posing a threat to Sou...

Shares in South Korea’s Hanjin KAL Co. have wiped out one-third of its value in the past two weeks after one of its major shareholders, once a...

South Korea’s diagnostic devices supplier Precision Biosensor Inc. has signed an export contract with Italian medical device company Borden Ch...

When a country’s currency weakens, foreign investors flee the local markets as a softer foreign-exchange rate usually means fragile economic f...

Hyosung TNC Corp., a South Korean textile and yarn maker, is showcasing the world’s first commercialized plant-based spandex at an internation...

Getting shots of a drug or vaccine over a long period is not easy for many people.That's probably why global biopharmaceutical companies and biotech...

Taekwang Industrial Co., a South Korean petrochemical and textile company, reported its first quarterly loss in 10 years amid weakness in its key bu...

  A lot of stock investors have jumped into the bullish market in recent years. But global inflation and recession appear as threats to invest...

South Korea’s major biopharmaceutical companies are rapidly embracing the cell and gene therapy business under a contract drug-making mechanis...

SK Discovery Co., an intermediate holding company of South Korea’s third-largest conglomerate SK Group, will take charge of the entire biotech...